• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION SENSIGHT; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION SENSIGHT; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS Back to Search Results
Model Number B3300542
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Headache (1880); Nausea (1970); Loss of consciousness (2418); Unspecified Nervous System Problem (4426)
Event Date 12/17/2023
Event Type  Death  
Manufacturer Narrative
Section d10 references: product id b32000 lot# 082m19323a implanted: (b)(6) 2023 product type accessory.Product id b31000 lot# 082t19323 implanted: (b)(6) 2023 product type accessory.Product id b3300542m serial# (b)(6) implanted: (b)(6) 2023 product type lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported by the nurse practitioner that the patient passed away on (b)(6) 2023.The patient's daughter said the patient had head pain.No other information had been provided as to the cause of death or of any hospitalization after the procedure (stage 1) on (b)(6) 2023. the cause of death was unknown at the time of this report.The manufacturer representative (rep) reported they were still seeking information.Additional information was received from the practice manager stating there was no correlation between the patient's death and the procedure, device, or therapy.Additional information received from the healthcare provider (hcp) reported prior to the deep brain stimulation (dbs) procedure the patient was seen for assessment.The patient had tremors in both the left and right hand which occurred all day.The patient had a history of arthritis, atrial fibrillation, gerd, h/o migraine, hyperlipidemia, mitral valve stenosis, myocardial infarction, gastritis, and osteoporosis.Medications included, aspirin, zyrtec, neurontin, beni car, imitrex, and coumadin.The patient elected to go through with surgery which went ¿perfectly well.¿ post-operatively a ct scan was completed which showed no significant abnormalities or signs of bleeding.The hcp noted surgery gone ¿perfectly well¿ and the patient was bridged on lovenox prior to their surgery, and did not start lovenox right after surgery for fear of hemorrhage or stroke.The patient did have some abnormal movements of the lower extremities which the hcp thought may have been related to zofran so they were given benadryl and the movements stopped and the headache resolved.In addition, there were some abnormalities in their blood work following surgery including hemoglobin 9.8, hematocrit 30.0, platelets 113, and rbc 2.95 which were all lower than prior to surgery.The patient was kept overnight and did well with a well-controlled headache and was discharged post-operative day one.Thepatient was instructed to avoid any bending, twisting, pushing, or pulling along with any lifting over 15 pounds.They were to report any erythema, edema, or drainage from the incision site or any temperature greater than 101.The patient was scheduled to return for the second phase of surgery the following week.On (b)(6) 2023 the hcp was made aware the patient passed away.The hcp spoke with the patient¿s family who stated the patient complained of a headache on (b)(6).At that time the patient was awake, nonfocal, able to move both upper and lower extremities, nauseated and was put to bed.When the patient went to check on them, they hadn¿t moved and were unresponsive.An ambulance was called who took them to the emergency room.A ct was performed, and they were told there was a very large acute hemorrhagic stroke; they did not recommend surgical intervention, but if they did move forward with surgical intervention, the patient would be hemiplegic and in a nursing home.The patient chose to have the patient extubated and die a natural death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENSIGHT
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key18747197
MDR Text Key335869949
Report Number2182207-2024-00808
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberB3300542
Device Catalogue NumberB3300542
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/15/2024
Date Device Manufactured10/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age62 YR
Patient SexFemale
Patient Weight75 KG
-
-